Results and problems in cell differentiation, Journal Year: 2024, Volume and Issue: unknown, P. 291 - 296
Published: Jan. 1, 2024
Language: Английский
Results and problems in cell differentiation, Journal Year: 2024, Volume and Issue: unknown, P. 291 - 296
Published: Jan. 1, 2024
Language: Английский
Alzheimer s Research & Therapy, Journal Year: 2024, Volume and Issue: 16(1)
Published: Oct. 23, 2024
Variants of the gene triggering receptor expressed on myeloid cells-2 (TREM2) increase risk Alzheimer's disease (AD) and other neurodegenerative disorders. Signaling by TREM2, an innate immune microglia, is thought to enhance phagocytosis amyloid beta (Aβ) damaged proteins, promote microglial proliferation, migration, survival, regulate inflammatory signaling. Thus, TREM2 activation has potential alter progression AD. AL002 investigational, engineered, humanized monoclonal immunoglobulin G1 (IgG1) antibody designed target TREM2. In AD mouse models, murine variant been previously shown induce proliferation reduce filamentous Aβ plaques neurite dystrophy.
Language: Английский
Citations
11Alzheimer s & Dementia, Journal Year: 2024, Volume and Issue: 20(8), P. 5720 - 5739
Published: June 2, 2024
Abstract Alzheimer's disease (AD) is a neurodegenerative that involves multiple systems in the body. Numerous recent studies have revealed bidirectional crosstalk between brain and bone, but interaction bone AD remains unclear. In this review, we summarize human of association provide an overview their interactions underlying mechanisms AD. We review effects on from aspects pathogenic proteins, risk genes, neurohormones, neuropeptides, neurotransmitters, brain‐derived extracellular vesicles (EVs), autonomic nervous system. Correspondingly, elucidate involvement pathogenesis AD, including bone‐derived hormones, marrow‐derived cells, EVs, inflammation. On basis brain, propose potential strategies for management with hope offering novel perspectives its prevention treatment. Highlights The along consequent changes may involve disturbing homeostasis. Degenerative disorders influence progression through series pathophysiological mechanisms. Therefore, relevant intervention be beneficial comprehensive
Language: Английский
Citations
7International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(17), P. 9475 - 9475
Published: Aug. 31, 2024
Alzheimer's disease (AD), the leading cause of dementia, is a multifactorial influenced by aging, genetics, and environmental factors. miRNAs are crucial regulators gene expression play significant roles in AD onset progression. This exploratory study analyzed levels 28 genes 5 (miR-124-3p, miR-125b-5p, miR-21-5p, miR-146a-5p, miR-155-5p) related to pathology neuroimmune responses using RT-qPCR. Analyses were conducted prefrontal cortex (PFC) hippocampus (HPC)
Language: Английский
Citations
4GeroScience, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 29, 2025
Language: Английский
Citations
0CNS Neuroscience & Therapeutics, Journal Year: 2025, Volume and Issue: 31(2)
Published: Feb. 1, 2025
ABSTRACT Background Osteopontin (OPN) has emerged as a pivotal molecule in Alzheimer's disease (AD), with studies indicating its potential to act both neuroprotective agent and contributor neurodegeneration. This systematic review aims elucidate the roles of OPN AD pathogenesis through inflammatory pathways. Methods We conducted comprehensive analysis current literature on OPN's involvement AD, focusing signaling pathways, cellular interactions, regulatory mechanisms. searched PubMed, EMBASE, Scopus databases by keyword Disease Osteopontin. Our date search was 1990 until July 1, 2024 no language limitation. Results In 758 studies, total 15 reports met eligibility criteria were included. Among findings, four provided evidence supporting protective mechanism within context AD. Eleven explain role OPN. been shown play synaptic pruning, microglial activation, processes associated Additionally, is implicated facilitating communication serves chemotactic molecule. It suggested that effects are predominantly mediated c fragment protein most prominent early stages progression. Conclusion dual effects—protecting neurons contributing their degeneration. Future research should enhance mechanisms, target specific develop therapies slow
Language: Английский
Citations
0Neurobiology of Disease, Journal Year: 2024, Volume and Issue: unknown, P. 106666 - 106666
Published: Sept. 1, 2024
Language: Английский
Citations
2Advances in medical technologies and clinical practice book series, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 23
Published: June 28, 2024
Alzheimer's disease (AD) is a progressive neurodegenerative that results in steady decline cognitive ability and memory function. As society ages, the need for an optimum AD management strategy becomes more important. This chapter analyzes stage-construction etiology escalating symptoms of discovered throughout this review, as well identification barrier to precise diagnosis. The artificial intelligence achieve quicker detection through machine learning, data analytics, predictive modeling also being considered. Therefore, employing AI AD-related studies novel approach enhancing patient outcomes. Proper diagnosis parallel increased probability many parameters one most difficult moments identify. However, use evaluation sensor network technologies big analysis has advanced, preventive instruments can be used. Thus, technology gives humanity hope stop or, at very least, slow down tragedy.
Language: Английский
Citations
1Osteoporosis International, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 7, 2024
Language: Английский
Citations
1Neural Regeneration Research, Journal Year: 2024, Volume and Issue: 20(7), P. 2068 - 2083
Published: May 10, 2024
JOURNAL/nrgr/04.03/01300535-202507000-00028/figure1/v/2024-09-09T124005Z/r/image-tiff Alzheimer’s disease is characterized by deposition of amyloid-β, which forms extracellular neuritic plaques, and accumulation hyperphosphorylated tau, aggregates to form intraneuronal neurofibrillary tangles, in the brain. The NLRP3 inflammasome may play a role transition from amyloid-β tau phosphorylation aggregation. Because primarily found brain microglia, predominantly located neurons, it has been suggested that expressed microglia indirectly triggers upregulating expression pro-inflammatory cytokines. Here, we neurons also express vitro vivo , neuronal regulates phosphorylation. Using biochemical methods, mapped minimal promoter identified FUBP3 as transcription factor regulating neurons. In primary neuroblastoma cell line Neuro2A, required for endogenous only when present. brains aged wild-type mice mouse model disease, was markedly increased cortical Transcriptome analysis plays neuron-mediated immune responses. We trimmed 5′ end DNA fragments bound, implying functions stress-induced These findings suggest be more directly involved amyloid-β-to–phospho-tau than microglial NLRP3, fundamentally alters regulatory mechanism Given at low levels young strongly upregulated mice, could safe therapeutic target preventing progression.
Language: Английский
Citations
0Results and problems in cell differentiation, Journal Year: 2024, Volume and Issue: unknown, P. 291 - 296
Published: Jan. 1, 2024
Language: Английский
Citations
0